Literature DB >> 5001751

Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping.

R Gold, J L Winklehake, R S Mars, M S Artenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5001751     DOI: 10.1093/infdis/124.6.593

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Outer membrane antigens of Neisseria meningitidis group B serotype 2 studied by crossed immunoelectrophoresis.

Authors:  G E Hoff; C E Frasch
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

2.  Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

Authors:  E Holten
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

3.  Rapid serotyping of groups A, B, and C meningococci by rocket-line immunoelectrophoresis and co-agglutination.

Authors:  D Danielsson; P Olcén
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

4.  Prevention of meningococcal disease: practice and prospects.

Authors:  T C Eickhoff
Journal:  West J Med       Date:  1978-03

5.  Meningococcus.

Authors:  E Slater
Journal:  West J Med       Date:  1977-10

6.  Classification of Neisseria meningitidis group B into distinct serotypes. II. Extraction of type-specific antigens for serotyping by precipitin techniques.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

7.  Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

Review 8.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

9.  Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine.

Authors:  H Käyhty
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

10.  Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera.

Authors:  J M Griffiss; D K Goroff
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.